Agent Capital is a biotech venture capital firm in Massachusetts that invests in seed and early stage ventures. Its portfolio companies include ImCheck Therapeutics, Pyxis Oncology, Entrada Therapeutics, Verge Genomics, Pliant Therapeutics, Carisma Therapeutics, Skyhawk Therapeutics, Precision BioSciences and Orchard Therapeutics. It usually invests in Series A, B and C rounds.
Agent Capital is a healthcare venture capital firm focused on companies that develop novel, differentiated therapeutics and treatments that address unmet patient needs.
Timeline
People
Bruce Peacock
VENTURE PARTNER
Geeta Vemuri, PhD, MBA
MANAGING PARTNER
John Glasspool
VENTURE PARTNER
Preston Noon, PharmD, MBA
PARTNER
Further reading
Documentaries, videos and podcasts
Companies
Carisma Therapeutics
Entrada Therapeutics
ImCheck Therapeutics
Orchard Therapeutics
Pliant Therapeutics
Precision BioSciences
Pyxis Oncology
Skyhawk Therapeutics
Verge Genomics
News
References
Company attributes
MassachusettsVenture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Jude Gomila
Founder and CEO of Golden, Entrepreneur. Investor in 200+ companies. Cantabrigian (Gonville and Caius). Interested in the Universe. - 3
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Henry Ogolla
Passionate about reading and writing. - 6
Carla Faraguna
Golden People and Operations. - 7
Charlie Hilton
Design at Golden.